Clinical Trials Browser

Phase 3 × Carcinoma, Transitional Cell × durvalumab × Clear all

NCT04637594 2026-03-20

IMAGINE

Phase 3 Active not recruiting

3 enrolled 6 charts

Carcinoma, Transitional Cell